VEGF in Iris Tissue in Primary Congenital Glaucoma
- Conditions
- Iris
- Interventions
- Other: Immunohistochemistry analysis
- Registration Number
- NCT05484050
- Lead Sponsor
- Hassan Lotfy Fahmy
- Brief Summary
Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen in primary congenital glaucoma through Immunohistochemistry.
- Detailed Description
Combined trabeculotomy with mitomycin C will done in infants with primary congenital glaucoma with histopathological examination of the the peripheral iris tissue specimen and vascular endothelial growth factor (VEGF) estimation in iris tissue specimen through Immunohistochemistry.
Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen taking from ocular trauma or congenital cataract used as control.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- primary congenital glaucoma
- Infants with history of previous surgery.
- Secondary glaucoma.
- Glaucoma associated with other congenital anomalies.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description VEGF in iris tissue in primary congenital glaucoma Immunohistochemistry analysis Estimation of VEGF grade in iris tissue in primary congenital glaucoma through Immunohistochemistry VEGF in iris tissue from ocular trauma or congenital cataract Immunohistochemistry analysis Estimation of VEGF grade in iris tissue from ocular trauma or congenital cataract through Immunohistochemistry
- Primary Outcome Measures
Name Time Method VEGF 6 month Estimation of VEGF grade in iris tissue through Immunohistochemistry, The grades is arranged from 0 to 5, with 0 being the lowest level and 5 being the highest level
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hassan Lotfy
🇪🇬Assiut, Egypt